This is what analysts have to say about Smith & Nephew plc (NYSE:SNN) after last week.

October 2, 2018 - By Marguerite Chambers

Smith & Nephew plc (NYSE:SNN) Logo

Smith & Nephew plc (NYSE:SNN) Ratings Coverage

Among 3 analysts covering Smith & Nephew Snats (NYSE:SNN), 1 have Buy rating, 1 Sell and 1 Hold. Therefore 33% are positive. Smith & Nephew Snats had 4 analyst reports since April 4, 2018 according to SRatingsIntel. The stock of Smith & Nephew plc (NYSE:SNN) has “Neutral” rating given on Wednesday, August 8 by UBS. The rating was downgraded by Deutsche Bank on Thursday, May 3 to “Sell”. The firm has “Buy” rating by Canaccord Genuity given on Wednesday, April 4. Below is a list of Smith & Nephew plc (NYSE:SNN) latest ratings and price target changes.

08/08/2018 Broker: UBS Old Rating: Buy New Rating: Neutral Downgrade
04/05/2018 Broker: Inc. Common Stock Rating: Deutsche Bank
03/05/2018 Broker: Deutsche Bank Rating: Sell Downgrade
04/04/2018 Broker: Canaccord Genuity Rating: Buy New Target: $45.0000 Maintain

The stock decreased 0.54% or $0.2 during the last trading session, reaching $36.94. About 66,167 shares traded. Smith & Nephew plc (NYSE:SNN) has risen 0.22% since October 2, 2017 and is uptrending. It has underperformed by 15.40% the S&P500.

Smith & Nephew plc designs, develops, and sells medical devices worldwide. The company has market cap of $15.54 billion. The firm offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints; and arthroscopic enabling technologies for healthcare providers, such as fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency wands, electromechanical and mechanical blades, and hand instruments for removing damaged tissue. It has a 22.55 P/E ratio. It also provides trauma and extremities products consisting of internal and external devices used in the stabilization of severe fractures and deformity correction procedures; robotics-assisted surgery services and products; knee implant products for specialized knee replacement procedures; and hip implant products for reconstruction of the hip joint, as well as various products and technologies to assist in surgical treatment of the ear, nose, and throat.

Another recent and important Smith & Nephew plc (NYSE:SNN) news was published by which published an article titled: “Form 6-K SMITH & NEPHEW PLC For: Oct 01” on October 01, 2018.

Smith & Nephew plc (NYSE:SNN) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News